1. Home
  2. TBPH vs BJRI Comparison

TBPH vs BJRI Comparison

Compare TBPH & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$20.04

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo BJ's Restaurants Inc.

BJRI

BJ's Restaurants Inc.

HOLD

Current Price

$44.49

Market Cap

871.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
BJRI
Founded
2013
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
871.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TBPH
BJRI
Price
$20.04
$44.49
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$27.80
$39.80
AVG Volume (30 Days)
439.2K
393.7K
Earning Date
02-25-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.21
EPS
0.58
1.34
Revenue
$80,327,000.00
$1,388,066,000.00
Revenue This Year
$70.78
$5.06
Revenue Next Year
N/A
$2.66
P/E Ratio
$34.48
$33.04
Revenue Growth
27.12
3.85
52 Week Low
$7.90
$28.46
52 Week High
$20.79
$47.02

Technical Indicators

Market Signals
Indicator
TBPH
BJRI
Relative Strength Index (RSI) 62.84 66.83
Support Level $18.41 $42.18
Resistance Level $20.79 $45.99
Average True Range (ATR) 0.71 1.51
MACD 0.12 0.19
Stochastic Oscillator 76.62 78.81

Price Performance

Historical Comparison
TBPH
BJRI

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About BJRI BJ's Restaurants Inc.

BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.

Share on Social Networks: